OLOMOUCINE

OLOMOUCINE
  • CAS No.:101622-51-9
Other grades of this product :
OLOMOUCINE Basic information
Product Name:OLOMOUCINE
Synonyms:6-BENYLAMINO-2-(2-HYDROXYETHYLAMINO)-9-METHYLPURINE;6-BENZYLAMINO-2-(2-HYDROXYETHYLAMINO)-9-METHYLPURINE;2-(2'-Hydroxyethylamino)-9-methyl-6-(benzylamino)purine;2-(hydroxyethylamino)-6-benzylamino-9-methylpurine;2-[[9-METHYL-6[(PHENYLMETHYL)AMINO]-9H-PURIN-2-YL]AMINO]-ETHANOL;2-(2-HYDROXYETHYLAMINO)-6-BENZYLAMINO-9-METHYLPURINE;N2-[(2-HYDROXYETHYL)]-N6-BENZYLADENINE;OLOMOUCINE
CAS:101622-51-9
MF:C15H18N6O
MW:298.34
EINECS:
Product Categories:Heterocyclic Compounds;Bases & Related Reagents;Heterocycles;Inhibitors;Nucleotides;inhibitor;Protein Kinase
Mol File:101622-51-9.mol
OLOMOUCINE Chemical Properties
Melting point 120-130 °C
Boiling point 579.6±60.0 °C(Predicted)
density 1.36
storage temp. -20°C
solubility DMSO, Methanol (Slightly)
form Solid
pka14.55±0.10(Predicted)
color White to off-white
CAS DataBase Reference101622-51-9(CAS DataBase Reference)
Safety Information
Safety Statements 24/25
WGK Germany 3
HS Code 29339980
MSDS Information
ProviderLanguage
SigmaAldrich English
ACROS English
OLOMOUCINE Usage And Synthesis
Chemical Propertieswhite to off-white solid
UsesA purine derivative which inhibits cyclin-dependent kinases and induces G1 arrest.
UsesA purine derivative which inhibits cyclin-dependent kinases and induces G1 arrest
Biological ActivityCyclin-dependent kinase inhibitor that competes for the ATP binding site of the kinase. Selectively inhibits cdc2/cyclin B (IC 50 = 7 μ M), cdk2/cyclin A (IC 50 = 7 μ M), cdk2/cyclin E (IC 50 = 7 μ M), cdk/p35 kinase (IC 50 = 3 μ M)? and ERK1/MAP kinase (IC 50 = 25 μ M). Arrests human fibroblasts in the G1 phase.
Biochem/physiol ActionsOlomoucine is a purine derivative which inhibits cyclin-dependent kinases and induces G arrest.
Enzyme inhibitorThis ATP site-competitive purine derivative (FW = 298.35 g/mol; CAS 101622-51-9), systematically named 6-benzylamino-2-[2-hydroxyethylamino]- 9-methylpurine, is a potent inhibitor of cyclin-dependent kinases, with an IC50 value of 7 μM for both cdk1 and cdk2 and an IC50 value of 3 μM for cdk5, arresting cells in G1. Olomoucine also inhibits cytokinin 7b-glucosyltransferase.
references[1]. vesel j, havlicek l, strnad m, et al. inhibition of cyclin-dependent kinases by purine analogues. eur j biochem. 1994 sep 1;224(2):771-86.[2]. abraham rt, acquarone m, andersen a, et al. cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. biol cell. 1995;83(2-3):105-20.[3]. tian ds, xie mj, yu zy, et al. cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats. brain res. 2007 mar 2;1135(1):177-85.
OLOMOUCINE Preparation Products And Raw materials

Welcome!

Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.

  • NO. 18 ,Wujiang Road, Wulidian Street, Jiangbei District, Chongqing
  • +86-23-6139-8061 +86-13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

Name

phone

company

email

message

Payment methods
Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye